Susquehanna International Group
RVMD icon

Susquehanna International Group’s Revolution Medicines RVMD Stock Holding History

Susquehanna International Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$99.1M Buy
1,019,200
+859,100
+537% +$86.7M 0.01% 837
2025
Q4 		$12.8M Sell
160,100
-68,200
-30% -$4.47M ﹤0.01% 2735
2025
Q3 		$10.7M Buy
228,300
+114,900
+101% +$4.5M ﹤0.01% 2959
2025
Q2 		$4.17M Sell
113,400
-18,200
-14% -$699K ﹤0.01% 4317
2025
Q1 		$4.65M Sell
131,600
-87,600
-40% -$3.56M ﹤0.01% 3783
2024
Q4 		$9.59M Buy
219,200
+8,200
+4% +$414K ﹤0.01% 2719
2024
Q3 		$9.57M Buy
211,000
+120,300
+133% +$5.24M ﹤0.01% 2673
2024
Q2 		$3.52M Buy
90,700
+45,300
+100% +$1.69M ﹤0.01% 4024
2024
Q1 		$1.46M Sell
45,400
-19,900
-30% -$590K ﹤0.01% 6064
2023
Q4 		$1.87M Sell
65,300
-2,500
-4% -$60.1K ﹤0.01% 5503
2023
Q3 		$1.88M Buy
67,800
+32,800
+94% +$973K ﹤0.01% 5262
2023
Q2 		$936K Buy
35,000
+8,400
+32% +$206K ﹤0.01% 6841
2023
Q1 		$576K Buy
26,600
+500
+2% +$12.3K ﹤0.01% 8221
2022
Q4 		$622K Buy
+26,100
New +$555K ﹤0.01% 7306
2022
Q2 		– Sell
-19,500
Closed -$497K – 13805
2022
Q1 		$497K Sell
19,500
-17,400
-47% -$379K ﹤0.01% 8999
2021
Q4 		$929K Sell
36,900
-2,200
-6% -$62K ﹤0.01% 7502
2021
Q3 		$1.08M Buy
39,100
+5,900
+18% +$172K ﹤0.01% 7365
2021
Q2 		$1.05M Buy
33,200
+24,400
+277% +$852K ﹤0.01% 7624
2021
Q1 		$404K Buy
+8,800
New +$395K ﹤0.01% 9966

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Susquehanna International Group's RVMD Position: Q1 2026 in Review

Susquehanna International Group reduced its Revolution Medicines (RVMD) stake by 72% in Q1 2026, selling an estimated $13.3M and leaving 51,385 shares worth $5M. The position accounts for ﹤0.01% of the portfolio, ranked #4223.

Susquehanna International Group first reported a position in RVMD in Q1 2020 and has held it in 24 quarters since. The position peaked at $14.6M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Susquehanna International Group held 51,385 shares of Revolution Medicines worth $5M as of Q1 2026.
  • Susquehanna International Group sold 131,836 Revolution Medicines shares in Q1 2026, an estimated $13.3M.
  • Revolution Medicines made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4223 holding.
  • Susquehanna International Group first reported a position in Revolution Medicines in Q1 2020 and has held it in 24 quarters since.
  • Susquehanna International Group's Revolution Medicines position peaked at $14.6M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.